Compare BRCC & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRCC | CRDL |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 96.3M | 97.3M |
| IPO Year | 2022 | 2017 |
| Metric | BRCC | CRDL |
|---|---|---|
| Price | $0.79 | $1.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $2.25 | ★ $9.00 |
| AVG Volume (30 Days) | 738.3K | ★ 929.1K |
| Earning Date | 05-04-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $398,263,000.00 | N/A |
| Revenue This Year | $9.68 | N/A |
| Revenue Next Year | $9.59 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1.73 | N/A |
| 52 Week Low | $0.60 | $0.77 |
| 52 Week High | $2.40 | $1.59 |
| Indicator | BRCC | CRDL |
|---|---|---|
| Relative Strength Index (RSI) | 48.68 | 75.53 |
| Support Level | $0.71 | $0.95 |
| Resistance Level | $1.09 | $1.57 |
| Average True Range (ATR) | 0.06 | 0.10 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 31.35 | 87.99 |
BRC Inc is a veteran-controlled company that serves premium coffee, content, and merchandise to active military, veterans, and first responders. It is committed to producing great coffee that consumers love, and high-quality merchandise that enables its community to showcase its brand. Its omnichannel distribution has three components: Direct to Consumer channel includes its e-commerce business, through which consumers order products online and products are shipped to them, Its wholesale channel includes products sold to an intermediary such as convenience, grocery, drug, and mass merchandise stores, who in turn sell those products to consumers, and Outpost channel includes revenue from its Company-operated and franchised Black Rifle Coffee retail coffee shop locations.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.